- Home
- CAC vs GRAL Comparison
CAC vs GRAL Comparison
Compare CAC & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- GRAL
- Stock Information
- Founded
- CAC 1875
- GRAL 2016
- Country
- CAC United States
- GRAL United States
- Employees
- CAC N/A
- GRAL N/A
- Industry
- CAC Major Banks
- GRAL
- Sector
- CAC Finance
- GRAL
- Exchange
- CAC Nasdaq
- GRAL NYSE
- Market Cap
- CAC N/A
- GRAL 1.3B
- IPO Year
- CAC 1997
- GRAL N/A
- Fundamental
- Price
- CAC $43.34
- GRAL $46.72
- Analyst Decision
- CAC Hold
- GRAL Buy
- Analyst Count
- CAC 3
- GRAL 3
- Target Price
- CAC $47.33
- GRAL $31.50
- AVG Volume (30 Days)
- CAC 56.5K
- GRAL 1.6M
- Earning Date
- CAC 07-29-2025
- GRAL 08-12-2025
- Dividend Yield
- CAC 3.88%
- GRAL N/A
- EPS Growth
- CAC 2.54
- GRAL N/A
- EPS
- CAC 3.09
- GRAL N/A
- Revenue
- CAC $184,324,000.00
- GRAL $130,711,000.00
- Revenue This Year
- CAC $40.83
- GRAL $19.52
- Revenue Next Year
- CAC $5.29
- GRAL $20.37
- P/E Ratio
- CAC $14.04
- GRAL N/A
- Revenue Growth
- CAC 13.26
- GRAL 30.47
- 52 Week Low
- CAC $31.79
- GRAL $12.33
- 52 Week High
- CAC $50.07
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- CAC 71.29
- GRAL N/A
- Support Level
- CAC $38.11
- GRAL N/A
- Resistance Level
- CAC $40.92
- GRAL N/A
- Average True Range (ATR)
- CAC 0.99
- GRAL 0.00
- MACD
- CAC 0.44
- GRAL 0.00
- Stochastic Oscillator
- CAC 99.26
- GRAL 0.00
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.